CTS Tampa has implemented the Ortho Vitros Anti-SARS-CoV-2 Total test which qualitatively detects antibody (including IgG and IgM) to SARS-CoV-2 S protein on April 20, 2020. Additionally, Vitalant Research Institute is offering the SARS-CoV-2 Reporter Viral Particle Neutralization (RVPN) test.
The situation is rapidly developing and we know you likely have many questions, but you can find all the current information here: Communications
We will be sending updates as we get more details to share with you!
CTS received notification from Sanochemia Pharmazeutika AG of their intent to immediately discontinu...
The COVID-19 pandemic has unveiled the huge challenges and risks health workers are facing globally ...
On September 14, 2020, our Phoenix laboratory began performing a portion of our alternate donor anti...
FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screen...
On June 13, 2019, CTS provided information regarding the manufacturer’s discontinuation of HIV...
As a reminder, CTS will be exhibiting this weekend at the AABB Annual Meeting in San Antonio, T...